During the past decade, Mercy Medical Center - Sioux City conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 193 clinical trials were completed, i.e. on average, 9650% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 48 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Medical Center - Sioux City" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 95 trials, followed by "National Cancer Institute (NCI)" with 87 trials sponsored, "Eastern Cooperative Oncology Group" with 33 trials sponsored, "SWOG Cancer Research Network" with 33 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 33 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Medical Center - Sioux City" #1 collaborator was "National Cancer Institute (NCI)" with 199 trials as a collaborator, "Cancer and Leukemia Group B" with 14 trials as a collaborator, "NCIC Clinical Trials Group" with 14 trials as a collaborator, "Eastern Cooperative Oncology Group" with 12 trials as a collaborator and "SWOG Cancer Research Network" with 11 trials as a collaborator. Other collaborators include 42 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Medical Center - Sioux City" are "Breast Cancer" (44 trials), "Lung Cancer" (25 trials), "Lymphoma" (19 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (16 trials) and "Leukemia" (13 trials). Many other conditions were trialed in "Mercy Medical Center - Sioux City" in a lesser frequency.

Most popular intervention types in "Mercy Medical Center - Sioux City" are "Drug" (245 trials), "Other" (127 trials), "Biological" (112 trials), "Radiation" (46 trials) and "Procedure" (32 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (61 trials), "placebo" (38 trials), "Quality-of-Life Assessment" (26 trials), "Bevacizumab" (24 trials) and "Paclitaxel" (24 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Medical Center - Sioux City" are 234 trials for "All" genders, 47 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Mercy Medical Center - Sioux City". undefined are not yet recruiting, 1 are recruiting, 60 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 195 completed trials in Mercy Medical Center - Sioux City, undefined suspended trials, and 33 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Medical Center - Sioux City, 17 "Phase 1" clinical trials were conducted, 139 "Phase 2" clinical trials and 126 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".